Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experience

Perren, TJ orcid.org/0000-0001-8472-8856 (1995) Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experience. British Journal of Cancer, 72 (4). pp. 1016-1019. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 1995 Stockton Press. This is article is distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License.
Keywords: epithelial ovarian cancer; premedication; paclitaxel
Dates:
  • Accepted: 4 April 1995
  • Published: October 1995
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Clinical Cancer Research (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 11 Jul 2016 14:46
Last Modified: 11 Jul 2016 14:46
Published Version: http://dx.doi.org/10.1038/bjc.1995.453
Status: Published
Publisher: Cancer Research UK
Identification Number: https://doi.org/10.1038/bjc.1995.453

Share / Export

Statistics